Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Tsai, Jih Jin ^a,b   Chokephaibulkit, Kulkanya ^c   Chen, Po Chih ^a,d   Liu, Li Teh ^e   Hsiao, Hui Mien ^f   Lo, Yu Chih ^g   Perng, Guey Chuen ^f,g  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c MAHIDOL UNIVERSITY   (Thailand)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Dengue; DHF; DSS; Endotoxin; Fever; Flavivirus; Hemorrhagic

Indexed keywords

ANTIVIRUS AGENT; ENDOTOXIN; IMMUNOGLOBULIN M; VIRUS RNA;

ABDOMINAL PAIN; AEDES ALBOPICTUS; BACTEREMIA; BLOOD ANALYSIS; BLOOD VESSEL PERMEABILITY; CHILL; CLINICAL FEATURE; CLINICAL PRACTICE; COGNITION; DENGUE; DISEASE SEVERITY; ECCHYMOSIS; EPISTAXIS; FACE; FEVER; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC DISTRIBUTION; GINGIVA BLEEDING; HEADACHE; HEMORRHAGIC SHOCK; HEPATOMEGALY; HUMAN; IRRITABILITY; MALAISE; MOSQUITO; MULTIPLE ORGAN FAILURE; OPPORTUNISTIC INFECTION; PAIN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PETECHIA; PLEURA EFFUSION; PRIORITY JOURNAL; REVIEW; SEPSIS; SHOCK; THROMBOCYTOPENIA; VIREMIA; VIRUS VIRULENCE; WEAKNESS; BACTERIAL PHENOMENA AND FUNCTIONS; BLOOD; DENGUE VIRUS; PHYSIOLOGY; TEMPERATURE; VIROLOGY;

FLAVIVIRUS;

BACTERIAL PHYSIOLOGICAL PHENOMENA; DENGUE VIRUS; ENDOTOXINS; HUMANS; IMMUNOGLOBULIN M; SEVERE DENGUE; TEMPERATURE;

EID: 84888997780     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-88     Document Type: Review

References (119)

1. WHO, Dengue Vaccine Development: The role of the WHO South-East Asia Regional Office Geneva: World Health Organization 2010
2. Can non-human primates serve as models for investigating dengue disease pathogenesis? Clark KB, Onlamoon N, Hsiao HM, Perng GC, Villinger F, Front in microbiol 2013 4 305
3. Dengue vaccines: new developments. Gusman MG, Drugs Future 2011 36 45 62
4. Dengue. Halstead SB, Lancet 2007 370 9599 1644 1652 10.1016/S0140- 6736(07)61687-0 17993365
5. Immune response to dengue virus and prospects for a vaccine. Murphy BR, Whitehead SS, Annu Rev Immunol 2011 29 587 619 10.1146/annurev-immunol-031210- 101315 21219187
6. Evaluation of diagnostic tests: dengue. Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, Enria DA, Farrar J, Gubler DJ, Guzman MG, Halstead SB, Hunsperger E, Kliks S, Margolis HS, Nathanson CM, Nguyen VC, Rizzo N, Vazquez S, Yoksan S, Nat Rev Microbiol 2010 8 12 Suppl 30 S38 21548185
7. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Rothman AL, Nat Rev Immunol 2011 11 8 532 543 10.1038/nri3014 21760609
8. Eventual role of asymptomatic cases of dengue for the introduction and spread of dengue viruses in non-endemic regions. Chastel C, Front in physiol 2012 3 70
9. The global distribution and burden of dengue. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI, Nature 2013 496 7446 504 507 10.1038/nature12060 23563266
10. Global climate change and its potential impact on disease transmission by salinity-tolerant mosquito vectors in coastal zones. Ramasamy R, Surendran SN, Front in physiol 2012 3 198
11. Locally acquired dengue - Key West, Florida, 2009-2010. CDC, MMWR 2010 59 19 577 581 20489680
12. Dengue research opportunities in the Americas. Laughlin CA, Morens DM, Cassetti MC, Costero-Saint Denis A, San Martin JL, Whitehead SS, Fauci AS, J Infect Dis 2012 206 7 1121 1127 10.1093/infdis/jis351 22782946
13. Dengue and hemorrhagic fever: a potential threat to public health in the United States. Morens DM, Fauci AS, Jama 2008 299 2 214 216 18182605
14. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. Pinheiro FP, Corber SJ, World Health Stat Q 1997 50 3-4 161 169 9477544
15. Dengue and dengue haemorrhagic fever. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV, Lancet 1998 352 9132 971 977 10.1016/S0140-6736(97)12483-7 9752834
16. WHO, Dengue guidelines for diagnosis, treatment, prevention and control Geneva: World Health Organization 2009
17. WHO, Dengue Haemorrhagic fever: diagnosis, treatment, prevention and control Geneva: World Health Organization 2 1997
18. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. Barniol J, Gaczkowski R, Barbato EV, da Cunha RV, Salgado D, Martinez E, Segarra CS, Pleites Sandoval EB, Mishra A, Laksono IS, Lum LC, Martinez JG, Nunez A, Balsameda A, Allende I, Ramirez G, Dimaano E, Thomacheck K, Akbar NA, Ooi EE, Villegas E, Hien TT, Farrar J, Horstick O, Kroeger A, Jaenisch T, BMC Infect Dis 2011 11 106 10.1186/1471-2334-11-106 21510901
19. Application of revised dengue classification criteria as a severity marker of dengue viral infection in Indonesia. Basuki PS, Budiyanto, Puspitasari D, Husada D, Darmowandowo W, Ismoedijanto, Soegijanto S, Yamanaka A, Southeast Asian J Trop Med Public Health 2010 41 5 1088 1094 21073029
20. WHO, Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Haemorrhagic Fever Geneva: SEARO Technical Publication Series Revised and expanded edition. 2011 60
21. Dengue: a continuing global threat. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW, Nat Rev Microbiol 2010 8 12 Suppl 7 S16 21079655
22. Epidemiology of dengue and dengue haemorrhagic fever. Halstead SB, Dengue and Dengue Haemorrhagic Fever Wallingford, England: CAB International, Gubler D.J.a.K. G, 1997 23 44
23. Dengue: defining protective versus pathologic immunity. Rothman AL, J Clin Invest 2004 113 7 946 951 15057297
24. WHO, The World Health Report Geneva: Life in the 21st century A vision for all. 1998
25. The importance of temperature for medical science. Chokephaibulkit K, Perng GC, Curr Top in Virol 2011 9 43 49
26. Dengue in the early febrile phase: Viremia and antibody responses. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Rothman AL, Ennis FA, Nisalak A, J Infect Dis 1997 176 2 322 330 10.1086/514048 9237696
27. Effects of temperature, metabolic inhibitors and some other factors on fluid-phase and adsorptive pinocytosis by rat peritoneal macrophages. Pratten MK, Lloyd JB, Biochem J 1979 180 3 567 571 486133
28. Temperature dependence of endocytosis mediated by the asialoglycoprotein receptor in isolated rat hepatocytes. Evidence for two potentially rate-limiting steps. Weigel PH, Oka JA, J Biol Chem 1981 256 6 2615 2617 6259136
29. Maintaining mosquito cell lines at high temperatures: effects on the replication of flaviviruses. Kuno G, Oliver A, In Vitr Cell Dev Biol 1989 25 2 193 196 10.1007/BF02626177
30. Increased yields of Japanese encephalitis virus in heat shocked cell cultures. Paranjape SP, Kadam VD, Deolankar RP, Acta Virol 1994 38 6 333 337 7793357
31. Infection of bone marrow cells by dengue virus in vivo. Noisakran S, Onlamoon N, Hsiao HM, Clark KB, Villinger F, Ansari AA, Perng GC, Exp Hematol 2012 40 3 250 259 e254 10.1016/j.exphem.2011.11.011 22193689
32. Endoscopic findings and management of dengue patients with upper gastrointestinal bleeding. Chiu YC, Wu KL, Kuo CH, Hu TH, Chou YP, Chuah SK, Kuo CM, Kee KM, Changchien CS, Liu JW, Chiu KW, Am J Trop Med Hyg 2005 73 2 441 444 16103618
33. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Sandler NG, Douek DC, Nat Rev Microbiol 2012 10 9 655 666 10.1038/nrmicro2848 22886237
34. Clinical correlates with immunopathogenesis in dengue haemorrhagic fever/dengue shock syndrome. Tan PS, Malays J Pathol 1993 15 1 41 47 8277789
35. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. Swank GM, Deitch EA, World j of surg 1996 20 4 411 417 10.1007/s002689900065
36. An evidence of intestinal mucosal injury in dengue infection. Vejchapipat P, Theamboonlers A, Chongsrisawat V, Poovorawan Y, Southeast Asian J Trop Med Public Health 2006 37 1 79 82 16771216
37. Capillary leakage in travelers with dengue infection: implications for pathogenesis. Meltzer E, Heyman Z, Bin H, Schwartz E, Am J Trop Med Hyg 2012 86 3 536 539 10.4269/ajtmh.2012.10-0670 22403332
38. Transport of lipopolysaccharide across the cell envelope: the long road of discovery. Ruiz N, Kahne D, Silhavy TJ, Nat Rev Microbiol 2009 7 9 677 683 10.1038/nrmicro2184 19633680
39. Endotoxin and dengue haemorrhagic fever. Usawattanakul W, Nimmannitya S, Sarabenjawong K, Tharavanij S, Southeast Asian J Trop Med Public Health 1986 17 1 8 12
40. Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity. van de Weg CA, Koraka P, van Gorp EC, Mairuhu AT, Supriatna M, Soemantri A, van de Vijver DA, Osterhaus AD, Martina BE, J Clin Virol 2012 53 1 38 42 10.1016/j.jcv.2011.09.028 22014848
41. Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Halstead SB, Udomsakdi S, Singharaj P, Nisalak A, Am J Trop Med Hyg 1969 18 6 984 996 5355244
42. Upper gastrointestinal bleeding in dengue fever. Tsai CJ, Kuo CH, Chen PC, Changcheng CS, Am J Gastroenterol 1991 86 1 33 35 1986551
43. Detection of dengue virus in platelets isolated from dengue patients. Noisakran S, Gibbons RV, Songprakhon P, Jairungsri A, Ajariyakhajorn C, Nisalak A, Jarman RG, Malasit P, Chokephaibulkit K, Perng GC, Southeast Asian J Trop Med Public Health 2009 40 2 253 262 19323010
44. Frequency alterations in key innate immune cell components in the peripheral blood of dengue patients detected by FACS analysis. Tsai JJ, Jen YH, Chang JS, Hsiao HM, Noisakran S, Perng GC, J Innate Immun 2011 3 5 530 540 10.1159/000322904 21335935
45. Cluster of staphylococcus aureus and dengue co-infection in Singapore. Chai LY, Lim PL, Lee CC, Hsu LY, Teoh YL, Lye DC, Krishnan P, Leo YS, Ann Acad Med Singapore 2007 36 10 847 850 17987236
46. Dengue hemorrhagic fever in infants. Hongsiriwon S, Southeast Asian J Trop Med Public Health 2002 33 1 49 55
47. Coinfections in dengue patients. Pancharoen C, Thisyakorn U, Pediatr Infect Dis J 1998 17 1 81 82 10.1097/00006454-199801000-00019 9469403
48. Concurrent dengue hemorrhagic fever and typhoid fever infection in adult: case report. Sudjana P, Jusuf H, Southeast Asian J Trop Med Public Health 1998 29 2 370 372 9886130
49. Dual infection by dengue virus and Shigella sonnei in patient returning from India. Charrel RN, Abboud M, Durand JP, Brouqui P, De Lamballerie X, Emerg Infect Dis 2003 9 2 271
50. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Lee IK, Liu JW, Yang KD, Am J Trop Med Hyg 2005 72 2 221 226 15741560
51. Fatal dengue hemorrhagic fever in adults: emphasizing the evolutionary Pre-fatal clinical and laboratory manifestations. Lee IK, Liu JW, Yang KD, PLoS Negl Trop Dis 2012 6 2 1532 10.1371/journal.pntd.0001532 22363829
52. Infection-associated hemophagocytic syndrome among patients with dengue shock syndrome and invasive aspergillosis: a case series and review of the literature. Larbcharoensub N, Aroonroch R, Kanoksil W, Leopairut J, Nitiyanant P, Khositseth A, Tangnararatchakit K, Chuansumrit A, Yoksan S, Southeast Asian J Trop Med Public Health 2011 42 5 1106 1112 22299436
53. Concurrent dengue and malaria. Charrel RN, Brouqui P, Foucault C, de Lamballerie X, Emerg Infect Dis 2005 11 7 1153 1154 10.3201/eid1107.041352 16032797
54. Concurrent dengue and malaria due to Plasmodium falciparum and P. vivax. Kaushik RM, Varma A, Kaushik R, Gaur KJ, Trans R Soc Trop Med Hyg 2007 101 10 1048 1050 10.1016/j.trstmh.2007.04.017 17568646
55. Episodes of concurrent dengue and malaria. Arya SC, M. LK, Nirmala A, Agarwal BK, George M, Arun M, Dengue Bull 2005 29 208 209
56. Dual infection by dengue virus and Plasmodium vivax in Alappuzha District, Kerala, India. Thangaratham PS, Jeevan MK, Rajendran R, Samuel PP, Tyagi BK, Jpn J Infect Dis 2006 59 3 211 212 16785712
57. Mixed infection due to leptospira and dengue. Kaur H, John M, Indian J Gastroenterol 2002 21 5 206
58. Mixed infection due to Leptospira and Dengue in a patient with pyrexia. Rele MC, Rasal A, Despande SD, Koppikar GV, Lahiri KR, Indian J Med Microbiol 2001 19 4 206 207 17664834
59. Dengue hemorrhagic shock and disseminated candidiasis. Suzuki S, Kitazawa T, Ota Y, Okugawa S, Tsukada K, Nukui Y, Hatakeyama S, Yamaguchi D, Matsuse S, Ishii T, Matsubara T, Yamauchi C, Ota S, Yahagi N, Fukayama M, Koike K, Intern Med 2007 46 13 1043 1046 10.2169/internalmedicine.46.6354 17603249
60. Germfree mice reared on an "antigen-free" diet. Hashimoto K, Handa H, Umehara K, Sasaki S, Lab Anim Sci 1978 28 1 38 45 633838
61. Natural autoantibodies. Coutinho A, Kazatchkine MD, Avrameas S, Curr Opin Immunol 1995 7 6 812 818 10.1016/0952-7915(95)80053-0 8679125
62. Autoimmunity: from physiology to pathology. Natural antibodies, mucosal immunity and development of B cell repertoire. Tlaskalova-Hogenova H, Mandel L, Stepankova R, Bartova J, Barot R, Leclerc M, Kovaru F, Trebichavsky I, Folia Biol (Praha) 1992 38 3-4 202 215 1426416
63. Natural IgM antibodies, the ignored weapons in tumour immunity. Brandlein S, Vollmers HP, Histol Histopathol 2004 19 3 897 905 15168352
64. Naturally occurring immunoglobulin M antibodies to Toxoplasma gondii in Japanese populations. Konishi E, Parasitology 1991 102 Pt 2 157 162 1852482
65. Natural IgM antibodies: from parias to parvenus. Vollmers HP, Brandlein S, Histol Histopathol 2006 21 12 1355 1366 16977586
66. Origin of murine B cell lineages. Kantor AB, Herzenberg LA, Annu Rev Immunol 1993 11 501 538 10.1146/annurev.iy.11.040193.002441 8476571
67. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J, J Exp Med 2000 192 2 271 280 10.1084/jem.192.2.271 10899913
68. The importance of natural IgM: scavenger, protector and regulator. Ehrenstein MR, Notley CA, Nat Rev Immunol 2010 10 11 778 786 10.1038/nri2849 20948548
69. Control of early viral and bacterial distribution and disease by natural antibodies. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM, Science 1999 286 5447 2156 2159 10.1126/science.286.5447.2156 10591647
70. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. Reid RR, Prodeus AP, Khan W, Hsu T, Rosen FS, Carroll MC, J Immunol 1997 159 2 970 975 9218618
71. Immunopathogenesis of dengue virus infections. Kurane I, Ennis FA, Dengue and Dengue Hemorrhagic Fever Wallingford, UK: CAB International, Gubler DJ, Kuno G, 1997 273 290
72. Hotta S, Newer problems of dengue research The Eighth Tropical Medicine Seminar: Kanazawa Medical University 1984
73. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Baumgarth N, Tung JW, Herzenberg LA, Springer Semin Immunopathol 2005 26 4 347 362 10.1007/s00281-004-0182-2 15633017
74. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J, J Exp Med 1998 188 12 2381 2386 10.1084/jem.188.12.2381 9858525
75. Age-related changes in the cellular composition of the thymus in children. Weerkamp F, de Haas EF, Naber BA, Comans-Bitter WM, Bogers AJ, van Dongen JJ, Staal FJ, J Allergy Clin Immunol 2005 115 4 834 840 10.1016/j.jaci.2004.10.031 15806007
76. An outbreak of dengue virus serotype 1 infection in Cixi, Ningbo, People's Republic of China, 2004, associated with a traveler from Thailand and high density of Aedes albopictus. Xu G, Dong H, Shi N, Liu S, Zhou A, Cheng Z, Chen G, Liu J, Fang T, Zhang H, Gu C, Tan X, Ye J, Xie S, Cao G, Am J Trop Med Hyg 2007 76 6 1182 1188 17556633
77. Pathogenetic mechanisms in dengue haemorrhagic fever: report of an international collaboratorive study. WHO, Bull WHO 1973 48 117 133 4575523
78. Clearance of endotoxin by platelets: role in increasing the accuracy of the Limulus gelation test and in combating experimental endotoxemia. Das J, Schwartz AA, Folkman J, Surgery 1973 74 2 235 240 4577805
79. Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes. Kou Z, Lim JY, Beltramello M, Quinn M, Chen H, Liu S, Martinez-Sobrido L, Diamond MS, Schlesinger JJ, de Silva A, Sallusto F, Jin X, Virology 2011 410 1 240 247 10.1016/j.virol.2010.11.007 21131015
80. Dengue virus multiplication in cultures of mouse peritoneal macrophages: effects of macrophage activators. Hotta H, Hotta S, Microbiol Immunol 1982 26 8 665 676 10.1111/j.1348-0421.1982.tb00210.x 7176969
81. Role of CD61(+) cells in thrombocytopenia of dengue patients. Noisakran S, Onlamoon N, Pattanapanyasat K, Hsiao HM, Songprakhon P, Angkasekwinai N, Chokephaibulkit K, Villinger F, Ansari AA, Perng GC, Int J Hematol 2012 96 5 600 610 10.1007/s12185-012-1175-x 22987294
82. The importance of hematopoietic progenitor cells in dengue. Tsai J-J, Liu L-T, Chang K, Wang S-H, Hsiao H-M, Clark KB, Perng GC, Ther Adv in Hematol 2012 3 1 59 71 10.1177/2040620711417660
83. Lipopolysaccharide endotoxins. Raetz CR, Whitfield C, Annu Rev Biochem 2002 71 635 700 10.1146/annurev.biochem.71.110601.135414 12045108
84. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. Rittig MG, Kaufmann A, Robins A, Shaw B, Sprenger H, Gemsa D, Foulongne V, Rouot B, Dornand J, J Leukoc Biol 2003 74 6 1045 1055 10.1189/jlb.0103015 12960272
85. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. Alonzo MT, Lacuesta TL, Dimaano EM, Kurosu T, Suarez LA, Mapua CA, Akeda Y, Matias RR, Kuter DJ, Nagata S, Natividad FF, Oishi K, J Infect Dis 2012 205 8 1321 1329 10.1093/infdis/jis180 22383677
86. Pathogenesis of dengue: challenges to molecular biology. Halstead SB, Science 1988 239 4839 476 481 10.1126/science.3277268 3277268
87. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Halstead SB, Nimmannitya S, Cohen SN, Yale J Biol Med 1970 42 5 311 328 5419206
88. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, Phanthumachinda B, Halstead SB, Am J Epidemiol 1984 120 5 653 669 6496446
89. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Green S, Rothman A, Curr Opin Infect Dis 2006 19 5 429 436 10.1097/01.qco. 0000244047.31135.fa 16940865
90. - 1998 dengue hemorrhagic fever epidemic in Taiwan. Chao DY, Lin TH, Hwang KP, Huang JH, Liu CC, King CC, Emerg Infect Dis 2004 10 3 552 554 10.3201/eid1003.020518 15116715
91. A travel medicine view of dengue and dengue hemorrhagic fever. Meltzer E, Schwartz E, Travel Med Infect Dis 2009 7 5 278 283 10.1016/j.tmaid.2009.05.002 19747662
92. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. Libraty DH, Acosta LP, Tallo V, Segubre-Mercado E, Bautista A, Potts JA, Jarman RG, Yoon IK, Gibbons RV, Brion JD, Capeding RZ, PLoS Med 2009 6 10 1000171 10.1371/journal.pmed.1000171 19859541
93. Serotype-specific differences in clinical manifestations of dengue. Balmaseda A, Hammond SN, Perez L, Tellez Y, Saborio SI, Mercado JC, Cuadra R, Rocha J, Perez MA, Silva S, Rocha C, Harris E, Am J Trop Med Hyg 2006 74 3 449 456 16525106
94. Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Thai KT, Binh TQ, Giao PT, Phuong HL, le Hung Q, Van Nam N, Nga TT, Groen J, Nagelkerke N, de Vries PJ, Trop Med Int Health 2005 10 4 379 386 10.1111/j.1365-3156.2005.01388.x 15807802
95. Dengue vaccines: challenge and confrontation. Perng GC, World J of Vaccines 2011 01 04 109 130 10.4236/wjv.2011.14012
96. Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset. Prince HE, Yeh C, Lape-Nixon M, Clin Vaccine Immunol 2011 18 11 1951 1956 10.1128/CVI.05278-11 21880858
97. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Kurane I, Comp Immunol Microbiol Infect Dis 2007 30 5-6 329 340 17645944
98. Understanding dengue pathogenesis: implications for vaccine design. Stephenson JR, Bull World Health Organ 2005 83 4 308 314 15868023
99. Immunologic hypo- or non-responder in natural dengue virus infection. Perng GC, Chokephaibulkit K, J Biomed Sci 2013 20 1 34 10.1186/1423-0127-20-34 23725050
100. Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. Barnes WJ, Rosen L, Am J Trop Med Hyg 1974 23 3 495 506 4150910
101. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Gubler DJ, Reed D, Rosen L, Hitchcock JR Jr, Am J Trop Med Hyg 1978 27 3 581 589 677371
102. Dengue And Dengue Hemorrhagic Fever. Wallingford, UK: CABI, Gubler DJGK, 1 1997
103. Dengue virus tropism in humanized mice recapitulates human dengue Fever. Mota J, Rico-Hesse R, PLoS One 2011 6 6 20762 10.1371/journal.pone.0020762 21695193
104. Dengue virus markers of virulence and pathogenicity. Rico-Hesse R, Future Virol 2009 4 6 581 10.2217/fvl.09.51 20161679
105. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM, da Rosa AT, Virology 1997 230 2 244 251 10.1006/viro.1997.8504 9143280
106. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG, Halstead SB, Lancet 1999 354 9188 1431 1434 10.1016/S0140-6736(99) 04015-5 10543670
107. Emergence and global spread of a dengue serotype 3, subtype III virus. Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM, Emerg Infect Dis 2003 9 7 800 809 10.3201/eid0907.030038 12899133
108. Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells. Puri B, Nelson WM, Henchal EA, Hoke CH, Eckels KH, Dubois DR, Porter KR, Hayes CG, J Gen Virol 1997 78 Pt 9 2287 2291 9292016
109. Microevolution and virulence of dengue viruses. Rico-Hesse R, Adv Virus Res 2003 59 315 341 14696333
110. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Rico-Hesse R, Virology 1990 174 2 479 493 10.1016/0042-6822(90)90102-W 2129562
111. Detection of the disease severity-related molecular differences among new Thai dengue-2 isolates in 1993, based on their structural proteins and major non-structural protein NS1 sequences. Thant KZ, Morita K, Igarashi A, Microbiol Immunol 1996 40 3 205 216 10.1111/j.1348-0421.1996.tb03336.x 8934675
112. Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. Chen W, Kawano H, Men R, Clark D, Lai CJ, J Virol 1995 69 8 5186 5190 7609092
113. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. Cologna R, Rico-Hesse R, J Virol 2003 77 7 3929 3938 10.1128/JVI.77.7.3929-3938.2003 12634353
114. Dengue: an update. Guzman MG, Kouri G, Lancet Infect Dis 2002 2 1 33 42 10.1016/S1473-3099(01)00171-2 11892494
115. Effect of age on outcome of secondary dengue 2 infections. Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB, Int J Infect Dis 2002 6 2 118 124 10.1016/S1201-9712(02)90072-X 12121599
116. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, Kanesa-Thasan N, Hayes CG, Watts DM, Am J Trop Med Hyg 2001 65 3 180 183 11561700
117. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J, Hill AV, J Infect Dis 2001 184 11 1369 1373 10.1086/324320 11709777
118. Patterns of disease among adults hospitalized with dengue infections. Malavige GN, Velathanthiri VG, Wijewickrama ES, Fernando S, Jayaratne SD, Aaskov J, Seneviratne SL, Qjm 2006 99 5 299 305 10.1093/qjmed/hcl039 16603571
119. Nutritional status of children with dengue hemorrhagic fever. Thisyakorn U, Nimmannitya S, Clin Infect Dis 1993 16 2 295 297 10.1093/clind/16.2.295 8443312